Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill

Biochem Mol Biol Int. 1999 Apr;47(4):707-14. doi: 10.1080/15216549900201773.

Abstract

Anti-tumor active polysaccharide against Sarcoma 180 was isolated by DEAE-Sepharose CL-6B and Sepharose 4B column chromatography from the hot-water soluble fraction of the mycelium of liquid-cultured Agaricus blazei mill. This polysaccharide did not react with antibodies of anti-tumor polysaccharides such as lentinan, gliforan, and FIII-2-b which is one of anti-tumor polysaccharides from Agaricus blazei. Moreover, the analyses of 13C-NMR and GC-MS suggested that this polysaccharide was preliminarily glucomannan with a main chain of beta-1,2-linked D-mannopyranosyl residues and beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl residues as a side chain. This polysaccharide was completely different from the anti-tumor polysaccharide from fruiting body of Agaricus blazei, beta-1,6-glucan.

MeSH terms

  • Agaricus / chemistry*
  • Animals
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Drug Screening Assays, Antitumor
  • Mice
  • Mice, Inbred ICR
  • Polysaccharides / isolation & purification
  • Polysaccharides / pharmacology*
  • Sarcoma 180 / drug therapy

Substances

  • Antineoplastic Agents
  • Polysaccharides